CPT added 94644 Continuous inhalation treatment with aerosol medication for acute airway obstruction; first hour and add-on code 94645 Continuous inhalation treatment with aerosol medication for acute ...
SPL84 is administered directly into the lungs where it is taken up by the cells and is expected to drive the production of fully functional CFTR proteins. The Food and Drug Administration (FDA) has ...
Please provide your email address to receive an email when new articles are posted on . Combining manuka honey and the antibiotic amikacin in a lab-based nebulization formulation was effective for ...
ENGLEWOOD, Colo., Jan. 14, 2021 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent ...
Aptar Digital Health’s Respiratory Disease Management Platform provides real-time usage tracking and encourages medication adherence through reminders and educational resources. The Food and Drug ...
Asthma is one of the most prevalent chronic inflammatory respiratory diseases across the globe, with a significant increase in mortality and morbidity in recent years, affecting all age groups ...
Based exclusively on the published evidence included in this review, inhaled GSH is potentially indicated for the following clinical conditions: cystic fibrosis (CF), chronic otitis media with ...
This study describes determinants affecting disease control and inhaled glucocorticosteroid therapy adherence for patients with asthma in western China. Objectives: This study aimed to evaluate ...
Inhaling low concentrations of ethanol vapor can disable the influenza A virus in mice, without harmful side effects, says a new study by scientists at the Okinawa Institute of Science and Technology ...
Hosted on MSN
MannKind Lands A Price-Target Hike After Partner United Therapeutics Reports Strong Lung Drug Trial Results
H.C. Wainwright on Tuesday raised its price target on MannKind to $11 from $9 and reiterated its buy rating on the shares, following positive late-stage study results from partner United Therapeutics ...
ENGLEWOOD, Colo., Jan. 14, 2021 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results